Covered Companies: enVVeno Medical
enVVeno Medical is an Irvine, California-based, late clinical-stage medical device company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease.
NASDAQ: NVNO
About
enVVeno Medical (Nasdaq: NVNO) is an Irvine, California-based, late clinical-stage medical device company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The Company’s lead product, the VenoValve®, is a first-in-class surgical replacement venous valve being developed for the treatment of deep venous Chronic Venous Insufficiency (CVI). The Company is also developing a non-surgical, transcatheter based replacement venous valve for the treatment of deep venous CVI called enVVe®. CVI occurs when valves inside of the veins of the leg become damaged, resulting in the backwards flow of blood (reflux), blood pooling in the lower leg, increased pressure in the veins of the leg (venous hypertension) and in severe cases, venous ulcers that are difficult to heal and become chronic. The Company estimates that there are approximately 2.5 million to 3.5 million people in the United States with severe CVI caused by malfunctioning valves Both the VenoValve® and enVVe® can potentially help these patients and are designed to act as one-way valves, to help in propelling blood up the leg, and back to the heart and lungs. The VenoValve® is currently being evaluated in the SAVVE® U.S. pivotal trial and the Company has reported initial positive topline efficacy data showing significant clinical improvement and clinical meaningful benefit at six months. The Company is currently performing the final testing necessary to seek approval for the enVVe® pivotal trial.
Join Us
Sign up for email alerts to stay up-to-date on the latest Virtual Investor events
By submitting this form, you are consenting to receive marketing emails from: Virtual Investor. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact